Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.


TSXV:THRM - Post by User

Comment by moonball32on Feb 16, 2022 3:37pm
110 Views
Post# 34435107

RE:Test

RE:TestYou just never know. If this was a game of pool I would say we all just got hustled. Pacify retail investors yesterday with what everyone was asking about and then today drop the hammer. I mean I get it, if yesterday's nr included that FDA had been applied for, all gains would have been wiped out with the PP. This way, when its released about FDA submission, there will be nice uptick, institutional investors sell at least 50% of their 20M shares and exercise warrants at FDA approval and sell remaining 50%, and ride the free warrant shares to whatever, can't blame them can you. Retail investors will always be left in the cold, just the way it is, as the saying goes the rich get richer. Don't get me wrong, it still sucks seeing a 20% drop. This drop will clear out most of the nervous Nellie's that were holding shares in the low 30's and high 20's. It's a wet dream for all the bashers and the told you so's. Holding steady and impatiently waiting.
<< Previous
Bullboard Posts
Next >>